Absence of toxicity of ornidazole after a 10-yr continuous daily use for Crohn's disease [6]

American Journal of Gastroenterology

Volumn 96, Issue 1, 2001, Pages 254-255

  Triantafillidis, John K ^a,b   Nicolakis, Dimitrios ^a   Antoniou, Aikaterini ^a   Hereti, Irini ^a  

^a Saint Panteleimon General Hospital   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; ORNIDAZOLE; TINIDAZOLE;

ADULT; CASE REPORT; CHRONIC DISEASE; CROHN DISEASE; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENTERITIS; HUMAN; ILEUM DISEASE; LETTER; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTOZOAL INFECTION;

EID: 0035133298     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02285-1     Document Type: Letter

References (10)

1. Ornidazole in the treatment of active Crohn's disease
2. Omidazole in the treatment of active Crohn's disease
3. Omidazole in the prevention of recurrence of Crohn's disease
4. Toxicity of ornidazole and its analogues to rat spermatozoa as reflected in motility parameters
5. Alternative treatment protocols in giardiasis: A pilot study
6. Treatment of symptomatic trichomoniasis among adult women using oral nitroimidazoles
7. Safety of nitroimidazoles
8. Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions
9. Peripheral neuropathy in Crohn's disease patients treated with metronidazole
10. Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole